You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
16 November 2020
CALYPSO BIOTECH SA: Calypso Biotech announces successful dosing of first Phase 1 cohort with anti-Interleukin-15 (IL-15) monoclonal antibody CALY-002 for the treatment of Autoimmune Diseases